MedKoo Biosciences

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

 

 

 


 

Back to products

 

 Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer agents in preclinical trials

Anticancer molecular libraries

 


Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

  

MedKoo product information:

 

CKI27 

  

Description of CKI27 (RG7304): CKI27 is a MEK inhibitor currently in clinical trials.

  

Current developer:   Roche/Chugai Pharmaceuticals.

   

MedKoo Code#:  205612

Name:  CKI27

CAS#:  

  

Synonym:   CKI27

  

IUPAC/Chemical name: 

  

 

Chemical structure

Theoretical analysis

 

 

 

 

 

 

  

Availability and price:

 

This agent is not in stock,  may be  available through  custom synthesis.

  

To inquire quotation and lead time or to ask questions, please send email to sales@medkoo.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.

 

 

Information about this agent

CKI (RG7304) is a MEK inhibitor currently in clinical trials.

 

 

References

 

 

 

Contact MedKoo:

Email: sales@medkoo.com

 

(Keyword; CAS#; MedKoo code#)

 

 

 

 

 

 

 

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

© MedKoo Biosciences. All Rights Reserved